Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond End Protection: Shelterin, POT1 Dysfunction, and Telomere Replication Stress in Cancer. | Biomolecules | 2026 | 42793176 | PubTator, text mining | PubMed |
| Paired Whole-Genome Sequencing of Scalp Angiosarcoma and Matched Lung Metastasis Reveals Common Clonal Origin and Lung-Specific Evolution. | Diagnostics (Basel) | 2026 | 42739253 | PubTator, text mining | PubMed |
| Demographics and factors influencing mortality among cardiac angiosarcoma patients and genomic studies correlation for future personalized management. | Proc (Bayl Univ Med Cent) | 2026 | 42659620 | PubTator, text mining | PubMed |
| Germline POT1 variants are associated with long telomeres and an unexpected broad spectrum of malignancies. | Genet Med Open | 2026 | 42656847 | PubTator, text mining | PubMed |
| Patient-partnered multiomics reveals the molecular architecture of angiosarcoma. | Nat Commun | 2026 | 42642422 | PubTator, text mining | PubMed |
| Familial melanoma: genetic, clinical, and dermoscopic insights and follow-up. | Front Med (Lausanne) | 2026 | 42577103 | PubTator, text mining | PubMed |
| Primary pulmonary presentation extranodal NK/T-cell lymphoma, small cell variant, illustrating the value of flow EBER in situ hybridisation assay. | J Hematop | 2026 | 42567998 | PubTator, text mining | PubMed |
| Novel blood lncRNA biomarkers associated with clinical severity and specific cognitive dimensions in Alzheimer's disease. | J Alzheimers Dis | 2026 | 42523149 | PubTator, text mining | PubMed |
| Telomere stability pathway genes as predictors of susceptibility and prognosis in urothelial bladder cancer: review and bioinformatics analyses. | J Toxicol Environ Health B Crit Rev | 2026 | 42521654 | PubTator, text mining | PubMed |
| Multiple Primary Melanomas and Metastatic Neuroendocrine Tumor in a POT1 Pathogenic Variant Carrier. | Int J Dermatol | 2026 | 42509648 | PubTator, text mining | PubMed |
| Meiotic telomeres of vole B chromosomes: shelterin and associated proteins provide a link to the nuclear envelope. | Chromosome Res | 2026 | 42479255 | PubTator, text mining | PubMed |
| Polystyrene nanoplastics are associated with telomere-associated alterations and senescence-related changes in intestinal epithelial cells involving PPARα-POT1 regulation. | Biochem Biophys Res Commun | 2026 | 42468176 | PubTator, text mining | PubMed |
| Correction: UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants. | J Med Genet | 2026 | 42463447 | PubTator, text mining | PubMed |
| Breast cancer phenotypes in carriers of pathogenic POT1 variants. | Fam Cancer | 2026 | 42430004 | PubTator, text mining | PubMed |
| Inhibition of lagging strand replication by G-rich telomeric DNA and the shelterin subunit POT1. | EMBO J | 2026 | 42426341 | PubTator, text mining | PubMed |
| The Role of Genetics in Malignant Melanoma: A Comprehensive Review. | Surg Clin North Am | 2026 | 42419313 | PubTator, text mining | PubMed |
| Impact of Multigene Panel Testing in High-Risk Uveal Melanoma Patients. | Pigment Cell Melanoma Res | 2026 | 42415513 | PubTator, text mining | PubMed |
| Microcystic Adnexal Carcinoma-like Neoplasm in a Patient With POT1 Mutation. | Cutis | 2026 | 42411896 | PubTator, text mining | PubMed |
| Genetic Determinants of Telomere Length and Their Role in Human Disease: Molecular Mechanisms and Underrepresented Populations' Perspectives. | Biomedicines | 2026 | 42351635 | PubTator, text mining | PubMed |
| Ibrutinib for early-stage CLL: genetic risk factors and treatment outcome in the GCLLSG CLL12 trial. | Blood | 2026 | 42322115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers